Bispecific Antibodies Drug Market: Transformative Growth Driven by Dual-Target Cancer Immunotherapies, Expanding Approvals, and Strong Oncology Pipeline Momentum
The Bispecific Antibodies Drug Market is undergoing transformative growth as dual-target cancer immunotherapies gain clinical traction, regulatory approvals expand, and a robust oncology pipeline continues to mature. Global bispecific antibody sales surpassed approximately USD 11–12 billion in 2024, and multiple forecasts project the market will reach between USD 22 and 50 billion by...
0 Comentários 0 Compartilhamentos 79 Visualizações 0 Anterior